maps • volume xv number 1 • Spring 2005
Spring 2005   download entire issue in   format
For past issues of the MAPS Bulletin, see the archives.
Html versions of each article can be seen by clicking on the titles.
  Front Cover
  Inside Front Cover      
  Table of contents      
2 Letter from Rick Doblin, MAPS President      
3 MDMA-Assisted Psychotherapy in the Treatment of Post Traumatic Stress Disorder, an Update
by Michael Mithoefer, MD      
4 MAPS' Medical Marijuana Research Efforts
by Rick Doblin, PhD      
6 MDMA-Assisted Psychotherapy in the Treatment of Anxiety in Advanced Cancer Patients
by John Halpern, MD      
7 MDMA and Basic Research: Issues Within and Beyond Therapeutic Applications
by Ilsa Jerome, PhD      
13 Neurocognitive Profile of Long Term Ecstasy Users, Proposed Research
by Philipp Ruessli      
14 Making Connections: MDMA Research on Mechanisms of Affiliation and Trust
by Alan Fiske, PhD      
17 Why I Support the Pill Testing Program (and you should too)
by Adam Wiggins      
18 LSD and Psilocybin in the Treatment of Cluster Headaches
by R. Andrew Sewell, MD      
19 Ayahuasca/EEG Research Progress Report and Invitation to Donate
by Frank Echenhoffer, PhD      
21 Ibogaine in the 21st Century: Boosters, Tune-ups and Maintenance
by Patrick K. Kroupa and Hattie Wells      
25 Ibogaine Outcome Study Progress Report
by Valerie Mojeiko      
27 A Psychedelic Neurochemistry of Time
by Kim A. Dawson, PhD      
30 Towards a Psychospiritual Understanding of Psychedelic Therapy: A Dissertation
by Sean G. House, PhD      
32 Heffter Research Institute: Update Spring 2005
by Dave Nichols, PhD      
34 The MAPS Online Benefit Auction      
35 The Albert Hofmann Foundation Report
by Myron Stolaroff      
37 Reducing Harm and Enhancing Benefit: A Report on MAPS at Burning Man 2004
by Brandy Doyle      
39 From a Sanctuary Client      
41 Letters to MAPS      
  Inside Back Cover      
  Back Cover
MAPS (Multidisciplinary Association for Psychedelic Studies) is a membership-based organization working to assist researchers worldwide to design, fund, conduct, obtain governmental approval for, and report on psychedelic research in humans. Founded in 1986, MAPS is an IRS approved 501 (c)(3) non-profit corporation funded by tax deductible donations.

MAPS is focused primarily on assisting scientists to conduct human studies to generate essential information about the risks and psychotherapeutic benefits of MDMA, other psychedelics, and marijuana, with the goal of eventually gaining government approval for their medical uses.

Interested parties wishing to copy any portion of this publication are encouraged to do so and are kindly requested to credit MAPS and include our address. The MAPS Bulletin is produced by a small group of dedicated staff and volunteers. Your participation, financial or otherwise, is welcome.

© 2005 Multidisciplinary Association
for Psychedelic Studies, Inc. (MAPS)
2105 Robinson Avenue,
Sarasota, FL 34232
Phone: 941-924-6277;
Toll-Free: 888-868-MAPS
Fax: 941-924-6265
Web: http://www.maps.org
ISSN 1080-8981
Printed on recycled paper
Bulletin Archive Index
Summer 2008 Vol. 18, No. 2 Phoenix Rising: A Review of MAPS Research
Winter 2008 Vol. 18, No. 1 Special Edition: Technology and Psychedelics
Winter 2007 Vol. 17, No. 3 MAPS 06-07 Fiscal Yearly Report
Autumn 2007 Vol. 17, No. 2 Special Edition: Psychedelics and Self-Discovery
Spring/Summer 2007 Vol. 17, No. 1 The Chrysalis Stage
Winter 2006-7 Vol. 16, No. 3 Low Maintenance/High Performance
Autumn 2006 Vol. 16, No. 2 Technologies of Healing
Spring 2006 Vol. 16, No. 1 MAPS' 20th Anniversary
Winter 2005 Vol. 15, No. 3 MAPS final year as a teenager
Summer 2005 Vol. 15, No. 2 Israel Conference: MDMA/PTSD Research
Spring 2005 Vol. 15, No. 1 Accelerating flow of work and time
Autumn 2004 Vol. 14, No. 2 Rites of Passage: Kids and Psychedelics
Summer 2004 Vol. 14, No. 1 10 stamps and $250,000
Winter 2003 Vol. 13, No. 2 Holy Fire
Spring 2003 Vol. 13, No. 1 60th Anniversary of the Discovery of LSD
Autumn 2002 Vol. 12, No. 3 Vision
Summer 2002 Vol. 12, No. 2 "From celebration to frustration, and back again."
Spring 2002 Vol. 12, No. 1 Sex, Spirit & Psychedelics 2002
Autumn 2001 Vol. 11, No. 2 "In the future, it will be called Despair."
Spring 2001 Vol. 11, No. 1 "A Tidal Wave of Ecstasy!"
Autumn 2000 Vol. 10, No. 3 Creativity 2000
Summer 2000 Vol. 10, No. 2 Endings and Beginnings
Spring 2000 Vol. 10, No. 1 Making History in Slow Motion
Winter 1999/00 Vol. 9, No. 4 To the Ends of the Earth for MDMA Research...
Autumn 1999 Vol. 9, No. 3 MAPS' long-standing efforts to conduct...
Summer 1999 Vol. 9, No. 2 MAPS has come full circle...
Spring 1999 Vol. 9, No. 1 Patience, persistence and passion
Winter 1998/99 Vol. 8, No. 4 One of special pleasures of directing MAPS...
Autumn 1998 Vol. 8, No. 3 The Ayahuasca Issue (with Hofmann interview)
Summer 1998 Vol. 8, No. 2 Emotionally Powerful Anecdotes...
Spring 1998 Vol. 8, No. 1 Death Has a Way of Focusing One's Attention
Autumn 1997 Vol. 7, No. 4 Celebration is in Order
Summer 1997 Vol. 7, No. 3 Time Horizons
Spring 1997 Vol. 7, No. 2 Synchronicity
Winter 1996/97 Vol. 7, No. 1 Learning to Crawl
Autumn 1996 Vol. 6, No. 4 An Invitation for Dialogue
Summer 1996 Vol. 6, No. 3 Budding Research
New Year 1996 Vol. 6, No. 2 Sending Down Roots
Autumn 1995 Vol. 6, No. 1 Baby Steps
Summer 1995 Vol. 5, No. 4 Opportunity Amidst Obstacles
Winter 1994/95 Vol. 5, No. 3 Clinical Trials and Tribulations
Autumn 1994 Vol. 5, No. 2 Building Towards Clinical Trials
Summer 1994 Vol. 5, No. 1 Politics and Protocols: In Search of a Balance
Spring 1994 Vol. 4, No. 4 Laying the Groundwork
Winter 1993/94 Vol. 4, No. 3 A Time of Tests
Summer 1993 Vol. 4, No. 2 So Close Yet So Far
Spring 1993 Vol. 4, No. 1 Remembrance and Renewal
Winter 1992/93 Vol. 3, No. 4 Forging New Alliances
Summer 1992 Vol. 3, No. 3 Building on Common Ground
Spring 1992 Vol. 3, No. 2 Small Steps, Gradual Progress, New Opportunities
Winter 1991/92 Vol. 3, No. 1 The Rekindling of a Thousand Points of Light
Summer 1991 Vol. 2, No. 2 MDMA protocol development with cancer patients
Winter 1990/91 Vol. 2, No. 1 MAPS' Swiss pharmacologically-assisted psychotherapy conference
Autumn 1990 Vol. 1, No. 3 What and Who is MAPS?
Summer 1989 Vol. 1, No. 2 Switzerland Leads the Way
Summer 1988 Vol. 1, No. 1 MDMA can become a legal medicine